Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort).
Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort).
复制标题
DOI:
10.3390/antiox11020379
复制
发表时间:
2022-02-14
期刊:
影响因子:
--
通讯作者:
On Behalf Of The Anrs/Afef Hepather Study Group
中科院分区:
文献类型:
--
作者:
Barré T;Fontaine H;Pol S;Ramier C;Di Beo V;Protopopescu C;Marcellin F;Bureau M;Bourlière M;Dorival C;Petrov-Sanchez V;Asselah T;Delarocque-Astagneau E;Larrey D;Duclos-Vallée JC;Carrat F;Carrieri P;On Behalf Of The Anrs/Afef Hepather Study Group
People living with chronic hepatitis B virus (HBV) infection are at high risk of liver disease progression, which is positively associated with metabolic disorders, but inversely associated with dyslipidemia. Diet, including dietary antioxidants, is a lever of metabolic disorder management. In particular, elevated coffee consumption is associated with different metabolic outcomes in the general population. We aimed to test whether such associations occur in HBV-infected people. Based on cross-sectional data from the ANRS CO22 Hepather cohort, we performed logistic regression models with (i) dyslipidemia, (ii) hypertension, and (iii) diabetes as outcomes, and with demographic, clinical, and socio-behavioral (including coffee consumption) data as explanatory variables. Among 4746 HBV-infected patients, drinking ≥3 cups of coffee per day was associated with a higher risk of dyslipidemia (adjusted odds ratio [95% confidence interval] 1.49 [1.10–2.00], p = 0.009) and a lower risk of hypertension (0.64 [0.50–0.82], p = 0.001). It was not associated with diabetes. Elevated coffee consumption was associated with a higher risk of dyslipidemia and a lower risk of hypertension in HBV-infected patients, two effects expected to be associated with favorable clinical outcomes. Further studies should test whether such metabolic benefits translate into reduced mortality risk in this population.
登录
查看更多内容
影响因子:
2.8
作者:
Liu D;Zhou L;Zhang X;Zeng Y;Bai L;Wu D;Tang H
通讯作者:
Tang H
影响因子:
1.3
作者:
Echeverri D;Montes FR;Cabrera M;Galán A;Prieto A
通讯作者:
Prieto A
影响因子:
7.1
作者:
Alperet, Derrick Johnston;Rebello, Salome Antonette;van Dam, Rob M.
通讯作者:
van Dam, Rob M.
DOI:
10.1080/03601234.2020.1724660
发表时间:
2020-02-17
影响因子:
2
作者:
Bobkova, Alica;Hudacek, Marek;Demianova, Alzbeta
通讯作者:
Demianova, Alzbeta
影响因子:
2.5
作者:
Barre, Tangui;Nishimwe, Marie Liberee;Carrieri, Patrizia
通讯作者:
Carrieri, Patrizia